Skip to main content

Published locations for Ocrelizumab subanalysis hints at better efficacy with active inflammatory lesions

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ocrelizumab subanalysis hints at better efficacy with active inflammatory lesions

User login

  • Reset your password
  • /content/ocrelizumab-subanalysis-hints-better-efficacy-active-inflammatory-lesions
  • /internalmedicinenews/article/106810/multiple-sclerosis/ocrelizumab-subanalysis-hints-better-efficacy
  • /multiplesclerosishub/article/106810/multiple-sclerosis/ocrelizumab-subanalysis-hints-better-efficacy
  • /internalmedicine/article/106810/multiple-sclerosis/ocrelizumab-subanalysis-hints-better-efficacy
  • /neurology/article/106810/multiple-sclerosis/ocrelizumab-subanalysis-hints-better-efficacy-active
  • /neurology/msresourcecenter/article/106810/multiple-sclerosis/ocrelizumab-subanalysis-hints-better
  • /clinicalneurologynews/article/106810/multiple-sclerosis/ocrelizumab-subanalysis-hints-better